Ovid Therapeutics (NASDAQ:OVID) Stock Has Consensus Target Price of $6.12 According to Analysts
MarketBeat
Mereo BioPharma Group plc - Sponsored ADR (NASDAQ:MREO) Stock Has Average Target Price of $1.67
MarketBeat
Leadsun Greentech enters EV charging with three DC fast-charging sites
DigiTimes: IT news from Asia


